Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Hansoh Pharmaceutical Group
Watchlist
HSCEI Index Rebalance: 9 Adds, 9 Deletes, BIG Turnover
Index Rebalance
440 Views
14 Nov 2020 23:07
There are 9 adds and 9 deletes in the upcoming HSCEI rebalance. Turnover at 10%+ is big and there is a lot of short interest on names. The momentum unwind last week presents interesting opportunities.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 10-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Loading
Trending Insights
More »
7&I (3382 JP) - Alimentation Couche-Tard Walks, Lobbing a Letter Bomb
UK Jobs Data And The Muddled MPC
Supreme Court's Final Ruling on Samsung's Lee Jae-Yong on 17 July: Impact on Samsung Group Companies
TSMC 2Q25: A Number of Very Positive Messages, Plus a Major Contradiction on 4Q25 Revenue
Seven & I Holdings (3382 JP): Dead Money as Couche-Tard Unsurprisingly Walks
Top Unpaywalled Insights
More »
Veon's (Nasdaq: VEON) Subsidiary Kyivstar Eyes Nasdaq Listing
Reimagining Venture Capital Through Impact Investing | Chris Maher on Disability Innovation
[IO Technicals 2025/28] Bullish Momentum Intensifies
Mid-Year Themes Review - Part II
De-Dollarisation Debate : Unmasking USD Over-Valuation
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Stock Connect - Secondary Listings and Biotech Stocks to Become Eligible?
24 Nov 2020
FTSE China 50 Index Rebalance Preview: Five Possible Change and HUGE Turnover
23 Nov 2020
HSCI Index Rebalance and Stock Connect: Early Look at Potential Changes
22 Nov 2020
HSCEI Index Rebalance: 9 Adds, 9 Deletes, BIG Turnover
14 Nov 2020
HSCEI Dec20 Index Rebalance Preview: One Week to Announcement
06 Nov 2020
HSCEI Index Rebalance Preview - December 2020: HUGE Number of Changes and Turnover Expected
17 Sep 2020
HSCEI Index Rebalance - Huge Turnover as WVRs & Secondary Listings Make Their Index Debut
15 Aug 2020
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.8
x